Clinical trial
A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With…
NCT00168792 · Boehringer Ingelheim, Industry · Terminated
Key facts
| NCT number | NCT00168792 |
|---|---|
| Title | A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention (PCI) as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction (ASSENT 4 PCI) |
| Official title | A Phase IIIb - IV, Randomised, Open Label Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early PCI as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction. ASSENT 4 PCI (Assessment of the Safety and Efficacy of a New… |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Collaborators | Genentech, Inc. Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Myocardial Infarction |
| Intervention type | Drug, Procedure |
| Interventions | Tenecteplase, PCI |
| Enrollment | 1,671 |
| Start date | Nov 1, 2003 |
| Primary completion | Jul 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Oct 29, 2013 |
| Countries | Austria, Belgium, Brazil, Canada, Czechia, France, Germany, Greece, Hungary, Ireland, Italy, Mexico and 6 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: